Compare PCVX & BVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | BVN |
|---|---|---|
| Founded | 2013 | 1953 |
| Country | United States | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.4B |
| IPO Year | 2020 | 1996 |
| Metric | PCVX | BVN |
|---|---|---|
| Price | $48.18 | $34.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $105.00 | $27.00 |
| AVG Volume (30 Days) | 1.1M | ★ 1.9M |
| Earning Date | 02-24-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | N/A | ★ 20.28 |
| EPS | N/A | ★ 1.70 |
| Revenue | N/A | ★ $1,407,837,000.00 |
| Revenue This Year | N/A | $30.26 |
| Revenue Next Year | N/A | $17.15 |
| P/E Ratio | ★ N/A | $19.84 |
| Revenue Growth | N/A | ★ 26.97 |
| 52 Week Low | $27.66 | $12.26 |
| 52 Week High | $93.77 | $35.43 |
| Indicator | PCVX | BVN |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | N/A |
| Support Level | $44.57 | N/A |
| Resistance Level | $49.55 | N/A |
| Average True Range (ATR) | 2.05 | 0.00 |
| MACD | 0.20 | 0.00 |
| Stochastic Oscillator | 75.56 | 0.00 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.